Blog 10/16/24
America has celebrated National Pharmacy Week during the third full week of October since 1925. Ninety-nine years later, most people still think of a pharmacist as the person in a white lab coat behind a counter. However, pharmacists have moved into roles beyond the counter. At Equitas Health, pharmacists began prescribing medications in 2020 as part of an integrated healthcare team. Behind and beyond the counter, Equitas Health pharmacists provide valuable treatment information to you and your doctors & nurses.
Before the COVID-19 pandemic made virtual healthcare – also known as telehealth – a necessity, Equitas Health had already launched its TelePrEP program. All over Ohio, TelePrEP helped increase access to PrEP, which is 99% effective at stopping HIV. With TelePrEP, people could see a pharmacist for their PrEP appointments who answered their questions, signed lab orders, provided STI counseling, and prescribed their PrEP medications.
Four years later, PrEP is now available as an injection. This means you have more options when it comes to preventing HIV. An Equitas Health pharmacist can help you decide which option is best for you. We want to thank our dedicated pharmacy professionals for everything they do all year to help the communities we serve get the most out of their PrEP treatment!
Celebrate National Pharmacy Week by learning how you can get PrEP at equitashealth.com/prep or call (833)-EQUITAS(378-4827) to make an appointment today!
Blog 10/16/24
Blog 7/29/24
Equitas Health, Ohio’s largest LGBTQ+ and HIV-serving healthcare organization, has announced new officers on the Board of Trustees. Susan McManus (she/her), vice president of business solutions marketing at Nationwide, will serve as Board chair for a one-year term through July 2025.
Blog 3/29/24
Equitas Health is pleased to announce that a collective bargaining agreement has been reached with Equitas Health Workers United Local #6609. Members of the bargaining unit voted this week, and the result was resounding support for ratification of the agreement.
Blog 3/25/24
Blog 3/1/24
Blog 2/27/24
Blog 10/16/24
Public Statement 9/21/24
Our focus remains on integrating our programs to better serve historically neglected communities, always with an understanding of the unique and intersectional needs of the diverse LGBTQ+ population.
Public Statement 8/26/24
Johnson & Johnson, one of the world’s largest drugmakers, announced last Friday that it will discontinue upfront 340B pricing on two medications for disproportionate share hospital (DSH) covered entities. The move is part of a sustained campaign by large drug manufacturers to undermine the federal 340B Drug Pricing Program for participating hospitals and covered entities such as Equitas Health.
